Table 3.
Means, ORs, and SEs for PSQI and Actigraphy Data
Outcome | YOCAS Group |
Control Group |
YOCAS-Control |
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | Preintervention |
Postintervention |
Within-Group Difference |
P | No. | Preintervention |
Postintervention |
Within-Group Difference |
P | Baseline Reference |
Between-Group Difference |
P‡ | |||||||||
Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Minutes | % | Mean* or OR† | SE | ||||||
PSQI | |||||||||||||||||||||
Global sleep quality | 168 | 9.20 | 0.25 | 7.23 | 0.26 | −1.96 | 0.25 | < .001 | 153 | 8.96 | 0.28 | 7.89 | 0.26 | −1.07 | 0.23 | .005 | −0.79* | 0.30 | .009 | ||
Sleep latency | 168 | 1.48 | 0.08 | 1.14 | 0.08 | −0.34 | 0.08 | .004 | 158 | 1.47 | 0.09 | 1.26 | 0.09 | −0.21 | 0.08 | .089 | 0.84† | 0.18 | .416 | ||
Sleep duration | 168 | 1.05 | 0.06 | 0.86 | 0.06 | −0.19 | 0.05 | .020 | 158 | 1.01 | 0.06 | 0.89 | 0.06 | −0.12 | 0.06 | .182 | 0.93† | 0.21 | .737 | ||
Sleep efficiency | 168 | 1.13 | 0.08 | 0.76 | 0.07 | −0.36 | 0.07 | .001 | 158 | 1.10 | 0.09 | 0.85 | 0.08 | −0.25 | 0.08 | .035 | 0.82† | 0.18 | .363 | ||
Sleep disturbance | 168 | 1.66 | 0.05 | 1.51 | 0.05 | −0.14 | 0.04 | .031 | 157 | 1.75 | 0.05 | 1.59 | 0.05 | −0.17 | 0.05 | .012 | 0.84† | 0.21 | .484 | ||
Daytime dysfunction | 168 | 1.30 | 0.05 | 0.93 | 0.05 | −0.38 | 0.05 | < .001 | 160 | 1.18 | 0.05 | 1.13 | 0.05 | −0.06 | 0.05 | .460 | 0.38† | 0.09 | < .001 | ||
Sleep medication use | 168 | 1.01 | 0.10 | 0.80 | 0.10 | −0.21 | 0.09 | .137 | 160 | 0.81 | 0.10 | 0.84 | 0.10 | 0.04 | 0.07 | .788 | 0.56† | 0.16 | .046 | ||
Subjective sleep quality | 168 | 1.57 | 0.05 | 1.22 | 0.05 | −0.35 | 0.06 | < .001 | 157 | 1.62 | 0.05 | 1.37 | 0.05 | −0.26 | 0.06 | .001 | 0.63† | 0.15 | .047 | ||
Actigraphy | |||||||||||||||||||||
Sleep onset latency | 157 | 30.49 | 2.72 | 28.56 | 2.18 | −1.94 | 2.17 | .579 | 147 | 34.5 | 2.94 | 31.59 | 3.12 | −2.90 | 2.64 | .499 | −7.05* | 2.98 | .813 | ||
Wake after sleep onset§ | 157 | 63.05 | 2.02 | 61.17 | 1.75 | −1.88 | 1.46 | .482 | 147 | 66.16 | 2.17 | 66.45 | 2.42 | 0.29 | 1.43 | .929 | 66 | −3.33* | 2.10 | .078 | |
80 | −7.39* | 1.28 | < .001 | ||||||||||||||||||
100 | −13.18* | 1.52 | < .001 | ||||||||||||||||||
150 | −27.68* | 3.01 | < .001 | ||||||||||||||||||
200 | −42.17* | 4.72 | < .001 | ||||||||||||||||||
Overall | < .001 | ||||||||||||||||||||
Sleep efficiency§ | 157 | 76.65 | 0.86 | 77.01 | 0.66 | 0.36 | 0.74 | .736 | 147 | 76.00 | 0.71 | 76.26 | 0.74 | 0.26 | 0.61 | .804 | 20 | 14.80* | 2.99 | .002 | |
40 | 9.69* | 1.97 | .002 | ||||||||||||||||||
60 | 4.57* | 1.05 | .004 | ||||||||||||||||||
75 | 0.74* | 1.68 | .354 | ||||||||||||||||||
Overall | .008 |
NOTE. Mean differences are reported at different baseline values when a significant arm-baseline interaction is present (ie, actigraphy end points). Pittsburgh Sleep Quality Index (PSQI) values represent actual scores on the measure, and actigraphy data are presented in minutes for sleep onset latency and wake after sleep onset, and as a percent for sleep efficiency. Within-group differences are expressed as mean difference for PSQI and actigraphy data. Between-group differences are expressed as mean differences for the global sleep quality PSQI score and actigraphy and as odds ratios (ORs) for the PSQI subscales with controls as the reference.
Abbreviation: YOCAS, Yoga for Cancer Survivors.
Mean values were obtained from analysis of covariance models.
ORs were obtained from ordinal logistic regression models.
Indicates a simultaneous test of the arm main effect and the arm-baseline interaction (ie, overall test of arm).
Indicates a significant arm-baseline interaction.